Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
06/2005
06/16/2005WO2005040116A3 Indolinone derivatives and their use in treating disease-states such as cancer
06/16/2005WO2005026145A3 Quinolone antibacterial agents
06/16/2005WO2005016326A3 Analogs of thalidomide as potential angiogenesis inhibitors
06/16/2005WO2005002552A3 Benzimidazole derivatives and their use as protein kinases inhibitors
06/16/2005WO2004046107A8 Indole derivatives as somatostatin agonists or antagonists
06/16/2005US20050131177 1-Alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators
06/16/2005US20050131050 Reacting ethyl trifluoroacetate with 4'fluoroacetophenone and 4-sulphonamidophenyl hydrazine
06/16/2005US20050131048 Enhancement of bone growth and inhibition of bone resorption
06/16/2005US20050131042 HIV protease inhibiting compounds
06/16/2005US20050131032 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors
06/16/2005US20050131022 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer
06/16/2005US20050131019 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents
06/16/2005US20050131018 Acetylene derivatives as inhibitors of histone deacetylase
06/16/2005US20050131016 Chemical compounds
06/16/2005US20050131014 Anticholesterol agents; antidiabetic agents; cardiovascular disorders ; antiarthritic agents
06/16/2005US20050131000 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
06/16/2005US20050130997 Pyrimidinone viral polymerase inhibitors
06/16/2005US20050130996 5-(4-{3-chloro-4-(3-fluorobenzyloxy)-anilino}-6-quinazolinyl)-furan-2-carbaldehyde; selective inhibition of the protein tyrosine kinase activity, minimising side effects
06/16/2005US20050130989 (3,5-Dimethyl-1-phenyl-1H-pyrazol-4-yl)(4-phenylpiperazin-1-yl)methanone; inhibit tubulin polymerization; cancer
06/16/2005US20050130981 Compounds
06/16/2005US20050130959 Selective in presence of at least one other cathepsin isozyme; such as (3-cyclopentyl-{[5-(3-fluoro-phenyl)-furan-2-carbonyl]-amino}-propionylamino)-4-oxo-butyric acid
06/16/2005US20050130903 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
06/16/2005US20050130244 for detection of 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-methamphetamine (MDMA) anibody production; drug screening; haptens; immunogens
06/16/2005US20050130243 For detection of 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-methamphetamine (MDMA) anibody production; drug screening; haptens; immunogens; kits
06/16/2005US20050130225 Ecstasy haptens and immunogens
06/16/2005CA2549242A1 Hydroxamic acid esters and pharmaceutical use thereof
06/16/2005CA2547887A1 Protein modifier production inhibitor
06/16/2005CA2547066A1 Advanced indolinone based protein kinase inhibitors
06/15/2005EP1541562A1 Novel uracil derivatives and medicinal use thereof
06/15/2005EP1541560A1 Novel tetrahydroquinoline derivatives
06/15/2005EP1541558A1 Heterocyclic compound having hiv integrase inhibitory activity
06/15/2005EP1541551A1 2-cyano-4-fluoropyrrolidine derivative or its salt
06/15/2005EP1539766A1 Calcitonin gene related peptide receptor antagonists
06/15/2005EP1539754A2 Benzimidazole quinolinones and uses thereof
06/15/2005EP1539748A1 2-phenylpyridin-4-yl derivatives as alk5 inhibitors
06/15/2005EP1539745A1 N-aryl-2-oxazolidinones and their derivatives
06/15/2005EP1539744A2 N-hydroxyamide derivatives possessing antibacterial activity
06/15/2005EP1539742A1 Indole derivatives useful as histamine h3 antagonists
06/15/2005EP1539741A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics
06/15/2005EP1539739A1 Piperidinyl compounds that selectively bind integrins
06/15/2005EP1539735A1 Piperazine urea derivatives as melanocortin-4 receptor agonists
06/15/2005EP1539718A1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
06/15/2005EP1539717A2 Microbiocidal (e.g fungicidal) 1,2,3-triazole derivatives
06/15/2005EP1539716A1 Benzodiazepine derivatives and pharmaceutical compositions containing them
06/15/2005EP1539712A1 Pyrimidine derivatives and their use as cb2 modulators
06/15/2005EP1539708A1 Benzimidazolones and their use as cytokine inhibitors
06/15/2005EP1539697A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs
06/15/2005EP1539693A1 Cannabinoid receptor agonists
06/15/2005EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands
06/15/2005EP1539178A2 Protease inhibitors
06/15/2005EP1539163A1 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors
06/15/2005EP1539158A1 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia
06/15/2005EP1539151A1 Biaryl compounds having anti-infective activity
06/15/2005EP1538907A2 Inhibitors of ftsz and uses thereof
06/15/2005EP1450808B1 Quinazoline derivatives for the treatment of t cell mediated diseases
06/15/2005EP1278740B1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
06/15/2005EP1256576B1 Fused imidazolium derivatives
06/15/2005EP1248785B1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
06/15/2005EP1140915B1 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
06/15/2005EP1048658B1 Alicyclic acylated heterocyclic derivatives
06/15/2005EP0923555B1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
06/15/2005EP0906108B1 Endothelin antagonists for treating heart failure
06/15/2005CN1628119A Derivatives of 2,2,4-trisubstiotuted tetrahydrofuran as anti fungal agents
06/15/2005CN1628114A Coumarines useful as biomarkers
06/15/2005CN1628100A Gamma secretase inhibitors
06/15/2005CN1628095A Diamine derivative, process for producing the same, and bactericide containing the same as active ingredient
06/15/2005CN1627945A Quinoline derivatives as NPY antagonists
06/15/2005CN1627944A Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
06/15/2005CN1626534A Steroid receptor modulator compounds and methods
06/15/2005CN1626530A Spiro and dispiro -1,2,4-trioxalane antimalarials
06/15/2005CN1626527A Pyran derivative, method for manufacturing the same, and light-emitting element containing the pyran derivative
06/15/2005CN1626077A Treatment of nuerodegenerative diseases
06/15/2005CN1206228C N-heterocyclic derivatives as NOS inhibitors
06/15/2005CN1206219C N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/14/2005US6906632 Vehicular sound-processing system incorporating an interior mirror user-interaction site for a restricted-range wireless communication system
06/14/2005US6906205 Spiro and dispiro 1,2,4-trioxolane antimalarials
06/14/2005US6906203 Anticancer agents; such as 2-Amino-3-cyano-4-(2-bromo-4,5-dimethoxyphenyl)-4H-indolo(4,5-b)pyran
06/14/2005US6906093 Indolinone combinatorial libraries and related products and methods for the treatment of disease
06/14/2005US6906089 Kidney disease; cardiovascular disorders; antiscarring agents; wound healing agents
06/14/2005US6906088 Taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions; anticarcinogenic agent
06/14/2005US6906085 Tetrahydropyran derivatives as neurokinin receptor antagonists
06/14/2005US6906081 For treatment of Alzheimer's disease, learning disabilities
06/14/2005US6906072 Central nervous system disorders
06/14/2005US6906070 Anticoagulants
06/14/2005US6906067 Block cytokine production via inhibition of p38 kinase; triamino-s-triazine compounds; treating rheumatoid arthritis
06/14/2005US6906066 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/14/2005US6906065 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
06/14/2005US6906063 For therapy and prophylaxis of thrombosis in a mammal
06/14/2005US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents
06/14/2005US6906051 Viricides, fungicides, microbiocides, osteoporosis
06/14/2005US6906007 Insecticides, miticides
06/14/2005US6906006 Applying to plants, environment
06/14/2005US6905786 A thin layer contains aromatic tert-amine compound, sandwiched between a pair of electrodes; brightness
06/14/2005CA2304967C 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
06/14/2005CA2247172C Novel 1(2h) quinoline carboxylic acid derivatives, method for preparing same, and use thereof for synthesising substances having antibiotic properties
06/14/2005CA2234096C 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
06/14/2005CA2155952C Novel process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
06/09/2005WO2005051944A1 Heterocyclyl-substituted oxetanes for the treatment of proliferative or infectious diseases
06/09/2005WO2005051938A1 Vitamin d receptor modulators
06/09/2005WO2005051923A1 Quinazoline derivatives
1 ... 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 ... 694